Conversely, in patients with MGMT unmethylated tumours, there was a non-significant trend favouring the radio-chemotherapy group (median overall survival being 10.0 vs. 7.9 months; HR = 0.75; p = 0.055) [38]. This evidence concerns the gene MGMT and neoplasm.